Search

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 608.95 -2.30  | -0.38% -35.02% 14.13 17,206.35
NSE Price: Oct 18, 10:49 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 10:49 608.95 -2.30 -0.38% 610.95 611.25 127,362 606.50 - 611.60
BSE Oct 18, 10:56 608.70 -2.20 -0.36% 611.00 610.90 12,556 607.05 - 611.80
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,369,908 P/B: 3.57 NSE Code: GLENMARK
52-Week Range: R 567.80 - 994.00 Dividend Yield: 0.33% BSE Code: 532296
TTM EPS: R 43.15 Book Value: R 170.95 Face Value: R 1
Price Graph
  • Alkem Laboratories (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. -31.20 1.35 -10.58 -32.70 -4.87 8.86 3.03
S&P BSE Mid Cap 33.94 0.89 6.03 21.23 20.21 19.43 7.80
S&P BSE Healthcare -3.01 3.79 -3.04 -10.88 1.98 13.51 14.21
Company's return has been calculated on basis of NSE's price.
As on Oct 17, 2017
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 20.07 15.16 17.69
Net Profit 49.22 26.66 19.02
EPS 49.18 25.26 18.22
Book Value 23.78 13.11 12.39
Average
Operating Margin 22.84 20.13 19.92
Net Margin 12.16 8.36 9.37
Return on Networth 27.31 21.19 21.38
Return on Investment 20.54 17.16 16.83
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -3.83 19.99 -3.83
Operating Profit 50.99 30.27 50.99
Net Profit 81.42 47.01 81.42
EPS 81.42 47.01 81.42
TTM
Revenue 4.29 20.29 4.29
Operating Profit 6.64 42.93 6.64
Net Profit 9.59 54.59 9.59
EPS 9.59 54.56 9.59
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 17,206.35 9,579.30 1,217.83 12.74 27.31 3.57 14.13
Alkem Laboratories 22,023.87 4,620.73 743.80 15.73 22.18 4.89 29.61
Torrent Pharmaceuticals 22,405.09 5,680.00 830.00 13.87 23.80 4.94 26.99
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 08, 2017 Oppenheimer Fund Inc(FII)  Buy Market 74,647 957.70 714.89
Nov 09, 2016 Robin Pinto  Buy Market 500 899.50 4.50
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 12,200 707.70 86.34
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 20,000 707.70 141.54
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 17,980 765.30 137.60
Fund Houses invested in the stock
Fund Sep-17 Jun-17 Mar-17 Dec-16 Sep-16
Aditya Birla Sun Life Mutual Fund 0.524 0.530 0.989 0.977 -
Reliance Mutual Fund 0.453 0.496 0.343 0.314 0.043
Kotak Mahindra Mutual Fund 0.380 0.464 0.156 0.117 0.063
Mirae Asset Mutual Fund 0.253 - - - -
HDFC Mutual Fund 0.243 0.170 0.146 0.113 0.139
Franklin Templeton Mutual Fund 0.228 0.107 - - -
IDFC Mutual Fund 0.145 0.079 0.050 0.091 0.031
Edelweiss Mutual Fund 0.100 0.006 0.003 - -
Axis Mutual Fund 0.084 0.004 0.004 - -
ICICI Prudential Mutual Fund 0.071 0.037 0.036 0.032 0.031
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: [email protected]

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
3.71
Piotroski F-Score
7
Modified C-Score
2
5-Years Price to Earnings
14.16
5-Years Price to Book
3.57
Earnings Yield
EBIT / Enterprise value
8.86%
PEG
Price / Earnings to growth ratio
0.48
Related Stocks
  Current Price   Chng %
Ajanta Pharma R1,194.10 -0.35%
Alembic Pharmaceuticals R500.00 -0.06%
Alkem Laboratories R1,833.00 +0.45%
Biocon R381.50 -1.14%
Divi's Laboratories R873.40 -1.03%
Glaxosmithkline Pharma R2,438.00 -0.56%
Jubilant Life Sciences R647.00 +0.51%
Natco Pharma R983.75 -0.30%
Sun Pharma Adv. Research R368.80 +0.26%
Torrent Pharmaceuticals R1,324.55 -0.42%
As on Oct 18, 10:53